Theralase Technologies Inc. V.TLT

wow, what a great day....

[riverrrow]

To buy more shares and warrants. TLT certainly has a knack of putting out muddled news releases that even seasoned investors have trouble making heads or tails of never mind newbies. Bottom line is that 4 out of 6 patients treated at the correct dosage have a complete response at 90 days for a CR of 66.6%. Without going into deeper details, the long term investors here know that the true results are 4 out of 5 patients with Complete Response at 90 days for a CR of 80%. I love buying shares in a proven company at a steep discount to true value that's trading under the radar in spite of its news releases. GLTA.

[enriquesuave]

I don't know what the market expected, but we knew that we would only get the same data as last Q  report plus patients 13-15. So far the treatment is showing at least 6 months durability just when patients will get treated a second time with an optimized treatment.  As for 13-15 so far 2 out of 3 are CR. Not bad.  Just need more data, and even if we just get good news from

[enriquesuave]

For the next report, it would be good to see the 3 months data for all pending patients and partial responders final confirmation as well as 9 months data ( 3 months after 2nd treatment).  We were just given data after one single treatment which is 3 and 6 months.  After 2nd treatment I hope we see all those CR maintaining CR status at 9 months and possibly a few more others become CR.

[enriquesuave]

"In accordance with FDA guidelines to industry, the patients who have achieved a PR are being further assessed via CT scan and biopsy of the prostatic urethra to determine if upper tract Urothelial Cell Carcinoma (“UCC”) or prostatic urethra UCC can be detected to allow these patients to be re-categorized as CR." Hope we get clarification on those 2 patients and pray that they come out

[CancerSlayer]

  Thanks for your informative posts enrique....But I'm actually hoping the results of the CT scans &/or prostatic biopsies are negative...for the sake of these two patients.  That is, the bladder cystoscopies simply missed residual CIS disease (i.e. falsely negative cystoscopy results).  False negatives certainly can happen depending on both the alertness/acumen of

[Pandora]

Sorry enrique but I have read it a couple of times and I find your statement as confusing or more confusing than the Company's news release.

[StevenBirch]

That's what I see, so it's back to accumulating when possible for the next 3 months.

[Longholder99]

riverrow I truly believe the complexity of what these people are doing, and the required reading is a barrier for many potential investors. Im on google and re reading many NRs...as well as relying on some very knowledgeable posters to keep informed. Many people dont want to to the homework and probably dont bother withva stock like this. So it doesnt get the pop that weed stocks and now

[tamarindo1]

I think many glance at the Accesswire highlights and don't take the trouble to read the newsletter in full or prior newsletters thus missing the total context. I get the feeling that later this week many will have a , "wait a minute" moment, and a pop-up may follow. Wouldn't be nice if there was a follow-up NR later in the week.  

[rodrabal]

This could have been such a great day for the stock if this news update had to have been worded better. Start with the headline,          SIX PATIENTS TREATED WITH RESULTS FROM THREE PATIENTS.TWO OUT OF THREE PATIENTS CANCER FREE (CR).  SIXTY SIX PERCENT (66%)  SUCCESS RATE.            Then go into the fine details. Like I said

[ramrodretired]

We are #1 0n the bullboard today! Someone is WATCHING LOL

[Pandora]

Not sure about anyone else but here I am having problems reading again:  "SIX PATIENTS TREATED WITH RESULTS FROM THREE PATIENTS." I stumble on that statement. Does it mean : "Six Patients have been treated. Results are given for three of those patients." Or does it mean something completely different?? i.e. did they really use the results from 3 patients to treat the 6